15-Hydroxyeicosatetraenoic acid
15-Hydroxyeicosatetraenoic acid[edit]

15-Hydroxyeicosatetraenoic acid (15-HETE) is a hydroxyeicosatetraenoic acid derived from the arachidonic acid metabolic pathway. It is a biologically active lipid mediator involved in various physiological and pathological processes.
Biosynthesis[edit]
15-HETE is primarily synthesized through the action of the enzyme 15-lipoxygenase (15-LOX) on arachidonic acid. This enzyme catalyzes the oxygenation of arachidonic acid to produce 15(S)-hydroperoxyeicosatetraenoic acid (15(S)-HPETE), which is subsequently reduced to 15(S)-HETE.
Biological Functions[edit]
15-HETE plays a role in the regulation of inflammation, immune response, and vascular homeostasis. It acts as a signaling molecule influencing the behavior of various cell types, including endothelial cells, smooth muscle cells, and leukocytes.
Inflammation[edit]
In the context of inflammation, 15-HETE can have both pro-inflammatory and anti-inflammatory effects, depending on the cellular context and the presence of other mediators. It is involved in the resolution phase of inflammation by promoting the clearance of inflammatory cells and the restoration of tissue homeostasis.
Vascular System[edit]
In the vascular system, 15-HETE modulates vasodilation and vasoconstriction, influencing blood flow and blood pressure. It can affect the function of endothelial cells and smooth muscle cells, contributing to the regulation of vascular tone.
Clinical Significance[edit]
15-HETE has been implicated in various diseases, including asthma, atherosclerosis, and certain types of cancer. Its levels are often altered in pathological conditions, making it a potential biomarker for disease diagnosis and progression.
Asthma[edit]
In asthma, 15-HETE is involved in the inflammatory response and airway remodeling. It can influence the contraction of airway smooth muscle and the production of mucus, contributing to the symptoms of asthma.
Atherosclerosis[edit]
In atherosclerosis, 15-HETE is involved in the formation of atherosclerotic plaques and the regulation of lipid metabolism. It can affect the behavior of macrophages and foam cells, playing a role in plaque stability and progression.
Related Pages[edit]
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian